AI Medical Technology omdelade detta
Skin cancer is the most common type of cancer in the U.S and melanoma is the deadliest form. According to the Melanoma Research Foundation, melanoma incidence in people under 30 has surged, increasing by 50% in women in particular since 1980. The increasing prevalence of melanoma is alarming, but with better diagnostics there is hope that these people can get faster treatment and face much better outcomes. Our solution, Dermalyser, is designed to revolutionise the diagnosis of melanoma. Dermalyser leverages advanced AI and deep learning to analyse skin images, providing healthcare practitioners with a powerful tool to detect melanoma earlier and more accurately, ensuring better treatment and improved survival rates. Find out more: https://lnkd.in/es6bMmvn